Geron Corp.

NASDAQ:GERN  
1.45
-0.04 (-3.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)444.88M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.08 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$1.45
50-Day MA$1.44
200-Day MA$1.72
See more pivots

Geron Corp. Stock, NASDAQ:GERN

919 East Hillsdale Boulevard, Suite 250, Foster City, California 94404
United States of America
Phone: +1.650.473.7700
Number of Employees: 55

Description

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.